Abstract:Introduction: Brain injury is the most common cause of death for patients resuscitated from cardiac arrest. Magnesium is an attractive neuroprotective therapy that has the potential to reduce neuronal calcium overload via NMDA receptor modulation and prevent mitochondrial permeability transition. Intramuscular (IM) delivery of MgSO4 during CPR has the potential to target these mechanisms within their presumed therapeutic window. Hypothesis: IM MgSO4 administrated during CPR will achieve therapeutic serum magnesium levels, which is ≥ 2 times of baseline, within 15 minutes after ROSC and improve neurologic outcomes. Methods: Male Long Evans rats were subjected to 8-minute asphyxial cardiac arrest. For the dose-finding study (n = 4/group), rats were block randomized to receive placebo, 107 mg/kg, 215 mg/kg, or 430 mg/kg MgSO4 IM at the onset of CPR. Serial blood samples were collected at baseline, 15 min, 30 minutes, 1 hour and 2 hours after return of spontaneous circulation (ROSC) and analyzed for serum magnesium concentration. For the long-term outcome study (n = 9/group), rats subjected to cardiac arrest were blindly block randomized to the same treatment groups with the addition of a sham-operated group. Post-cardiac arrest care included maintenance of normothermia (36.7 °C - 37.3 °C) for 72 hours. Serial blood samples were collected at baseline, 15 min and 1 hour after ROSC and neurologic function score (NFS) was performed daily for 10 days. Good neurologic function was predefined as NFS ≥ 450. Results: IM MgSO4 during CPR had no effect on ROSC rate (p > 0.05). The serum magnesium concentrations at 15 min after ROSC of 107 mg/kg group, 215 mg/kg group and 430 mg/kg group were 3.9 ± 0.9, 6.2 ± 1.8, and 7.6 ± 1.8 mg/dl, which were 2.0 fold, 3.1 fold and 4.2 fold of baseline respectively. IM MgSO4 had no statistically significant effect on 10-day survival or 10-day survival with good neurologic function. Conclusion: Single dose IM MgSO4 during CPR achieves up to 4-fold baseline magnesium levels within 15 min after ROSC in a rat model of asphyxia cardiac arrest. This treatment strategy did not improve survival or recovery of neurologic function. Future studies with repeated dosing or in combination with hypothermic targeted temperature management may be indicated.

Abstract 104: Taurine As Biomarker and Therapeutic Target for Cardiac Arrest

Abstract 218: Novel Blood Biomarker Taurine and Glutamate for Early Predicting Outcomes after Out-of-hospital Cardiac Arrest

Abstract 332: Novel Peptide Administered During CPR Improves Long-Term Survival after Prolonged Cardiac Arrest

Insight into the Mechanisms of Therapeutic Hypothermia for Asphyxia Cardiac Arrest Using a Comprehensive Approach of GC-MS/MS and UPLC-Q-TOF-MS/MS Based on Serum Metabolomics

Abstract 276: TAT-PTEN9c Targets Heart Directly to Improve Survival from Cardiac Arrest

Diverse NKT cells regulate early inflammation and neurological outcomes after cardiac arrest and resuscitation

Abstract 101: PHLPP Inhibitory Peptide Administered During CPR Improves Survival after Prolonged Cardiac Arrest

Combination of hyperoxygenation and targeted temperature management improves functional outcomes of post cardiac arrest syndrome irrespective of causes of arrest in rats

Abstract 175: Cerebral and Myocardial Mitochondrial Injury Differ in a Rat Model of Cardiac Arrest

Abstract 120: Artesunate Reduces the Severity of Post-Resuscitation Myocardial and Cerebral Dysfunction

Spontaneous Hypothermia Ameliorated Inflammation and Neurologic Deficit in Rat Cardiac Arrest Models Following Resuscitation

Abstract 323: A Peptide Inhibitor of PTEN Improves Mouse Survival after Cardiac Arrest

Targeted Temperature Management for Cardiac Arrest Due to Non-shockable Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Modification of T cells function after restoration of spontaneous circulation in a rat model of cardiac arrest

Abstract 11243: Novel Peptide for Cardiopulmonary Resuscitation

Abstract 13483: Peptide Inhibition of PTEN Improves Metabolic Recovery and Outcomes in a Murine Cardiac Arrest Model

Impaired Cerebral Mitochondrial Oxidative Phosphorylation Function in a Rat Model of Ventricular Fibrillation and Cardiopulmonary Resuscitation

Abstract 123: Intra-arrest Delivery of Intra-muscular Magnesium Sulfate in a Rat Model of Cardiac Arrest

A Cell-Penetrating PHLPP Peptide Improves Cardiac Arrest Survival in Murine and Swine Models.

Effects of ω-3 PUFA and ascorbic acid combination on post-resuscitation myocardial function

Abstract 250: Effects of Mild Hypothermia on Cerebral Lactate Metabolism in a Rat Model of Cardiac Arrest